📣 VC round data is live. Check it out!

Coltene Valuation Multiples

Discover revenue and EBITDA valuation multiples for Coltene and similar public comparables like TaiDoc Technology, Universal Vision, IVF hartmann, ClearPoint Neuro and more.

Coltene Overview

About Coltene

Coltene Holding AG is a Switzerland based company engaged in developing, manufacturing, and selling a range of disposables and tools for dentists and dental laboratories. The company divides its comprehensive product range into categories such as Infection Control, Dental Preservation, and Efficient Treatment categories. It offers products like aspirator tips, high-performance rotary instruments, dental dams and root canal instruments among others. The firm has its geographic presence in EMEA, North America, Latin America, and Asia/Oceania regions.


Founded

2005

HQ

Switzerland

Employees

1.2K

Financials (LTM)

Revenue: $305M
EBITDA: $37M

EV

$414M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Coltene Financials

Coltene reported last 12-month revenue of $305M and EBITDA of $37M.

In the same LTM period, Coltene generated $203M in gross profit, $37M in EBITDA, and $21M in net income.

Revenue (LTM)


Coltene P&L

In the most recent fiscal year, Coltene reported revenue of $308M and EBITDA of $36M.

Coltene is profitable as of last fiscal year, with gross margin of 62%, EBITDA margin of 12%, and net margin of 6%.

See analyst estimates for Coltene
LTMLast FY202320242025202620272028
Revenue$305M$308M$309M$318M$305M
Gross Profit$203M$190M$187M$200M$190M
Gross Margin66%62%60%63%62%
EBITDA$37M$36M$30M$44M$33M
EBITDA Margin12%12%10%14%11%
EBIT Margin9%9%8%11%9%
Net Profit$21M$19M$15M$26M$19M
Net Margin7%6%5%8%6%
Net Debt-$34M---

Financial data powered by Morningstar, Inc.

Coltene Stock Performance

Coltene has current market cap of $380M, and enterprise value of $414M.

Market Cap Evolution


Coltene's stock price is $63.60.

Coltene share price decreased by 3.2% in the last 30 days, and by 26.3% in the last year.

Coltene has an EPS (earnings per share) of $3.20.

See more trading valuation data for Coltene
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$414M$380M0.8%-3.2%5.2%-26.3%$3.20

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Coltene Valuation Multiples

Coltene trades at 1.4x EV/Revenue multiple, and 11.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Coltene

EV / Revenue (LTM)


Coltene Financial Valuation Multiples

As of June 3, 2026, Coltene has market cap of $380M and EV of $414M.

Coltene has a P/E ratio of 18.3x.

LTMLast FY202320242025202620272028
EV/Revenue1.4x1.3x1.3x1.3x1.4x
EV/EBITDA11.1x11.4x13.7x9.5x12.4x
EV/EBIT14.5x15.4x16.6x12.1x15.5x
EV/Gross Profit2.0x2.2x2.2x2.1x2.2x
P/E18.3x19.9x25.0x14.6x20.0x
EV/FCF22.1x27.8x18.8x14.2x42.3x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Coltene Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Coltene Margins & Growth Rates

Coltene decreased revenue by 2% but EBITDA grew by 8% in the last fiscal year.

In the most recent fiscal year, Coltene reported gross margin of 62%, EBITDA margin of 12%, and net margin of 6%.

See estimated margins and future growth rates for Coltene

Coltene Margins

Last FY202420252026202720282029
Gross Margin62%63%62%66%
EBITDA Margin12%14%11%13%
EBIT Margin9%11%9%10%
Net Margin6%8%6%8%
FCF Margin5%9%3%8%

Coltene Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(2%)3%(4%)(1%)
Gross Profit Growth6%7%(5%)6%
EBITDA Growth8%44%(24%)17%
EBIT Growth13%37%(22%)14%
Net Profit Growth21%71%(27%)22%
FCF Growth61%32%(66%)144%

Data powered by FactSet, Inc. and Morningstar, Inc.

Coltene Operational KPIs

Coltene's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Coltene's Rule of 40 is 12% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Coltene's Rule of X is 10% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Coltene
LTMLast FY202320242025202620272028
Rule of 4012%12%---
Bessemer Rule of X12%10%---
Revenue per Employee-$0.3M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue-3%3%3%3%
G&A Expenses to Revenue-10%9%10%10%
Opex to Revenue-53%52%52%53%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Coltene Competitors

Coltene competitors include TaiDoc Technology, Universal Vision, IVF hartmann, ClearPoint Neuro, Orthofix Medical, Delcath Systems, VieMed, Senseonics Holdings, Myriad Genetics and Medios.

Most Coltene public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
TaiDoc Technology1.8x-4.1x-
Universal Vision2.5x2.5x5.6x5.8x
IVF hartmann1.1x-7.0x-
ClearPoint Neuro10.8x9.1x(26.2x)(23.0x)
Orthofix Medical0.7x0.6x6.4x6.2x
Delcath Systems3.2x3.0x11.0x17.3x
VieMed1.4x1.3x6.0x5.7x
Senseonics Holdings9.5x7.2x(5.4x)-

This data is available for Pro users. Sign up to see all Coltene competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Coltene

When was Coltene founded?Coltene was founded in 2005.
Where is Coltene headquartered?Coltene is headquartered in Switzerland.
How many employees does Coltene have?As of today, Coltene has over 1K employees.
Is Coltene publicly listed?Yes, Coltene is a public company listed on SIX Swiss Exchange.
What is the stock symbol of Coltene?Coltene trades under CLTN ticker.
When did Coltene go public?Coltene went public in 2006.
Who are competitors of Coltene?Coltene main competitors include TaiDoc Technology, Universal Vision, IVF hartmann, ClearPoint Neuro, Orthofix Medical, Delcath Systems, VieMed, Senseonics Holdings, Myriad Genetics, Medios.
What is the current market cap of Coltene?Coltene's current market cap is $380M.
What is the current revenue of Coltene?Coltene's last 12 months revenue is $305M.
What is the current revenue growth of Coltene?Coltene revenue growth (NTM/LTM) is (0%).
What is the current EV/Revenue multiple of Coltene?Current revenue multiple of Coltene is 1.4x.
What is the current EBITDA of Coltene?Coltene's last 12 months EBITDA is $37M.
What is Coltene's EBITDA margin?Coltene's last 12 months EBITDA margin is 12%.
What is the current EV/EBITDA multiple of Coltene?Current EBITDA multiple of Coltene is 11.1x.
What is the current FCF of Coltene?Coltene's last 12 months FCF is $19M.
What is Coltene's FCF margin?Coltene's last 12 months FCF margin is 6%.
What is the current EV/FCF multiple of Coltene?Current FCF multiple of Coltene is 22.1x.
How many companies Coltene has acquired to date?Coltene hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Coltene has invested to date?Coltene hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Coltene

Lists including Coltene

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial